期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肿瘤睾丸抗原CT45-5在DNA损伤应答中的作用

Role of Cancer Testis Antigen CT45-5 in DNA Damage Response
下载PDF
导出
摘要 目的:用建立的CT45-5-siRNA研究肿瘤睾丸抗原CT45-5在DNA损伤应答中的作用。方法:通过靶向CT45-5基因小干扰RNA(siRNA)下调CT45-5的表达,用MTT比色法检测经喜树碱和依托泊苷处理后细胞对DNA损伤诱导剂的敏感性,用流式细胞技术检测电离辐射后细胞周期的变化。结果:在DNA损伤诱导剂处理后,在脆性组氨酸三联体(Fhit)高表达细胞中下调CT45-5的表达可以使细胞表现出更强的G2期阻滞及对DNA损伤诱导剂更耐受,而在Fhit缺失表达的细胞中却没有此现象。结论:CT45-5可能是以Fhit依赖的途径参与了DNA损伤应答。 Objective： To investigate the role of cancer testis antigen CT45-5 in DNA damage response by using CT45-5-siRNA. Methods： After CT45-5 gene was knocked down by siRNA and treatment with camptothecin （CPT） or etoposide（Et） or ionizing radiation（IR）, the stable cell lines 3-18, overexpressing human fragile histi- dine triad（Fhit）, were harvested at different time, cell survival fractions and cell cycles were tested by using MTT assay or flow cytometry. Results： The cells overxpressing Fhit by knocking down CT45-5 gene showed stronger G2 checkpoint response to IR and more resistant to CPT and Et-induced killing than control cells following DNA damage inducer. Conclusion： CT45-5 may involve in the DNA demage response by Fhit-dependent pathway.
作者 柯波 绳纪坡 于芳 林宇翔 罗维 胡宝成
机构地区 军事医学科学院生物工程研究所 福建农林大学生命科学院
出处 《生物技术通讯》 CAS 2013年第2期157-160,共4页 Letters in Biotechnology
基金 国家自然科学基金(31070760 30770651 30670616)
关键词 肿瘤睾丸抗原CT45—5 RNA干扰 DNA损伤应答 脆性组氨酸三联体 cancer testis antigen CT45-5 small interfering RNA DNA demage response fragile histidine triad
分类号 Q25 [生物学—细胞生物学] Q78 [生物学—分子生物学]
  • 相关文献

参考文献14

  • 1Chen Y T, Russ D S, Chiu R, et al. Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast caneers[J]. PLuS One, 2011,6(3): el7876.
  • 2Scanlan M J, Gure A O, Jungbluth A A, et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy[J], Immanol Rev, 2002,188:22-32.
  • 3Chen Y T, Chadburn A, Lee P, et al. Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas[J]. Proc Natl Acad Sei USA, 2010,107(7): 3093-3098.
  • 4Lira S H, Ztmng Y, Zhang J, et al. Cancer-testis antigens: the current status on antigen regulation and potential clinieal use[J]. Am J Blood Res, 2012,2( 1):29-35.
  • 5Caballero O L, Chen Y T. Cancer/testis(CT) antigens: potential targets for immunotherapy[J]. Cancer Sci, 2009,100:2014- 2021.
  • 6Chen Y T, Scanlan M J, Venditti C A, et al. Identification of cancer_testis-antigen genes by massively parallel signature sequencing[J]. Proc Natl Acad Sci USA, 2005,102(22):7940- 7945.
  • 7Chen Y T, Hsu M, Lee P, et al. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer[J]. lnt J Cancer, 2009,124:2893-2898.
  • 8张勇,张鸿声,于芳,绳纪坡,高宁,胡宝成.肿瘤-睾丸抗原CT45-5的表达纯化及多克隆抗体的制备[J].军事医学科学院院刊,2009,33(4):333-336. 被引量：2
  • 9Hu B, Han S Y, Wang X, et al. Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHKI pathway [J]. J Cell Physiol, 2005,202(2):518-523.
  • 10Hu B, Wang H, Wang X, et al. Fhit and CHK1 have opposing effects on homologous recombination repair[J]. Cancer Res, 2005,65(19):8613-8616.

二级参考文献11

  • 1Scanlan MJ,Simpson AJ,Old LJ,et al.The cancer/ testis genes:review,standardization,and commentary[J].Cancer Immun,2004,4(1):1-15.
  • 2Simpson AJ,Caballero OL,Jungbluth A,et al.Cancer/testis antigens,gametogenesis and cancer[J].Nat Rev Cancer,2005,5(8):615-625.
  • 3Ross MT,Grafham DV,Coffey AJ,et al.The DNA sequence of the human X chromosome[J].Nature,2005,434(7031):325-337.
  • 4Sahin U,Tureci O,Chen YT,et al.Expression of multiple cancer/testis(CT) antigens in breast cancer and melanoma:basis for polyvalent CT vaccine strategies[J].Int J Cancer,1998,78(3):387-389.
  • 5Sharma P,Shen Y,Wen S,et al.Cancer-testis antigens:expression and correlation with survival in human urothelial carcinoma[J].Clin Cancer Res,2006,12(18):5442-5447.
  • 6Tajima K,Obata Y,Tamaki H,et al.Expression of cancer/testis (CT) antigens in lung cancer[J].Lung Cancer,2003,42(1):23-33.
  • 7Gnjatic S,Nishikawa H,Jungbluth AA,et al.NY-ESO-1:review of an immunogenic tumor antigen[J].Adv Cancer Res,2006,95(1):1-30.
  • 8Heidebrecht HJ,Claviez A,Kruse ML,et al.Characterization and expression of CT45 in Hodgkin′s lymphoma[J].Clin Cancer Res,2006,12(16):4804-4811.
  • 9Chen YT,Hsu M,Lee P,et al.Cancer/testis antigen CT45:analysis of mRNA and protein expression in human cancer[J].Int J Cancer,2009,124(12):2893-2898.
  • 10Andrade VC,Vettore AL,Regis Silva MR,et al.Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma[J].Exp Hematol,2009,37(4):446-449.

共引文献1

生物技术通讯
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部